Joshua Solomon

Associate Professor of Medicine

National Jewish Health

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Joshua Solomon is an Associate Professor of Medicine at National Jewish Health in the United States. His research areas primarily focus on interstitial lung disease, rheumatoid arthritis-associated pulmonary fibrosis, and digital therapies for anxiety related to pulmonary conditions. His recent publications include studies on diagnostic classifiers for idiopathic pulmonary fibrosis and guidelines for the management of interstitial lung disease in systemic autoimmune rheumatic diseases.

Articles (16)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (6)

Min Jae Cha

Chung Ang University Hospital

SOUTH KOREA

View details

Ilya Ivlev

Associate Professor

Oregon Health & Science University

UNITED STATES

View details

Rohit Aggarwal

University of Pittsburgh Medical Center

UNITED STATES

View details

Kum Ju Chae

Jeonbuk National University (JBNU)

SOUTH KOREA

View details

Mary Strek

Professor of Medicine

University of Chicago Medicine

UNITED STATES

View details

Sindhu R Johnson

University of Toronto

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Joshua Solomon

Research Interests

Explore related searches

Contact this professor

About

Articles (16)

Quantitative CT Scan Analysis in Rheumatoid Arthritis-Related Interstitial Lung Disease

Response

Transforming growth factor-beta is increased in sputum from individuals with rheumatoid arthritis-associated pulmonary fibrosis

A digital therapy targeting anxiety in pulmonary fibrosis: A decentralized randomized controlled trial

Development and validation of a clinical, CT, genomic classifier and BAL scoring system for diagnosing idiopathic pulmonary fibrosis

Pragmatic Comparative Effectiveness Trials in Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Multiperspective Qualitative Study

Chronic Lung Injury after COVID-19 Pneumonia: Clinical, Radiologic, and Histopathologic Perspectives

2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases.

2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases.

2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases.

Interstitial Lung Disease Patients’ Global Impressions of Symptoms, Severity Ratings, and Meaningfulness of Changes Over Time

Pirfenidone in fibrotic hypersensitivity pneumonitis: a double-blind, randomised clinical trial of efficacy and safety

The attitudes and practices of physicians caring for patients with rheumatoid arthritis-associated interstitial lung disease: an international survey

Severe chronic cough relating to post-COVID-19 interstitial lung disease: a case report

CT of Post-Acute Lung Complications of COVID-19

Design and rationale of a randomised, double-blind trial of the efficacy and safety of pirfenidone in patients with fibrotic hypersensitivity pneumonitis

Collaborators (6)

Min Jae Cha

Ilya Ivlev

Rohit Aggarwal

Kum Ju Chae

Mary Strek

Sindhu R Johnson

Make your next move.